Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAP: Long-term Effectiveness of Phentermine
NCT05176626Phase 4Active, not recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and Overweight comparing Phentermine with Placebo (2 arms). Primary endpoints: Change in body weight at 24 months and Change in Systolic Blood Pressure at 24 months. Started Jun 2022; status: active, not recruiting.
02
Drugs
phentermine
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT05176626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05176626.